Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis
Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Inflammatory Bowel Diseases
DOI: 10.1002/ibd.21853
Authors: Haruhiko Ogata, Jun Kato, Fumihito Hirai, Nobuyuki Hida, Toshiyuki Matsui, Takayuki Matsumoto, Katsuyoshi Koyanagi, Toshifumi Hibi
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keywords: tacrolimus, FK506
Open Access status: closed
OpenAlex ID: W2104097403
